Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the Price/OCF ratio high or low?
The Price/OCF ratio of 80.03 is 25% below its estimated 1-year average of 106.08, near the low end of its estimated 1-year range (80.03–137.92).
As of 2026-10-06T12:01:04.418Z.
Calculation as of: 2026-10-06T12:01:04.418Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b9d80053686f16721d19c62710da14dda18ff2c6e5fba2adc15c1c35f0ac96a2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
80.03
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
17.00
median of 144 covered companies
CURRENT VS SECTOR MEDIAN
+370.90%
vs the sector median at left
Arcutis Biotherapeutics, Inc.
Market Cap
$3.15B
Price/OCF Ratio
80.03
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.16B
Price/OCF Ratio
N/A
TTM Avg
16.06
3Y Avg
20.39
5Y Avg
20.39
Market Cap
$3.09B
Price/OCF Ratio
N/A
TTM Avg
18.86
3Y Avg
18.86
5Y Avg
18.86
Market Cap
$2.87B
Price/OCF Ratio
19.65
TTM Avg
24.35
3Y Avg
65.42
5Y Avg
65.42
Market Cap
$3.44B
Price/OCF Ratio
17.72
TTM Avg
27.05
3Y Avg
38.50
5Y Avg
38.50
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | $3.15B | 80.03 | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | N/A | 16.06 | 20.39 | 20.39 |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | N/A | 18.86 | 18.86 | 18.86 |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.25B | N/A | N/A | N/A | N/A |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 19.65 | 24.35 | 65.42 | 65.42 |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 44.15 | 33.50 | 475.62 | 475.62 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | 17.72 | 27.05 | 38.50 | 38.50 |
| Celcuity Inc. (CELC)vs › | $3.59B | N/A | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 16.01 | 17.24 | 48.15 | 48.31 |
P/OCF Ratio
80.0
P/FCF Ratio
80.3
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2026-10-05 | 86.95 |
| 2026-10-02 | 86.98 |
| 2026-10-01 | 87.43 |
| 2026-09-30 | 91.37 |
| 2026-09-29 | 92.48 |
| 2026-09-28 | 94.48 |
| 2026-09-25 | 93.07 |
| 2026-09-24 | 90.82 |
| 2026-09-23 | 91.20 |
| 2026-09-22 | 96.04 |
| 2026-09-21 | 89.75 |
| 2026-09-18 | 87.74 |
| 2026-09-17 | 91.48 |
| 2026-09-16 | 90.37 |
| 2026-09-15 | 81.28 |
| 2026-09-14 | 83.91 |
| 2026-09-11 | 82.59 |
| 2026-09-10 | 80.83 |
| 2026-09-09 | 82.42 |
| 2026-09-08 | 84.32 |
| 2026-09-04 | 82.63 |
| 2026-09-03 | 81.80 |
| 2026-09-02 | 82.45 |
| 2026-09-01 | 82.11 |
| 2026-08-31 | 82.87 |
| 2026-08-28 | 82.21 |
| 2026-08-27 | 85.98 |
| 2026-08-26 | 86.91 |
| 2026-08-25 | 85.95 |
| 2026-08-24 | 85.67 |
| 2026-08-21 | 86.71 |
| 2026-08-20 | 87.64 |
| 2026-08-19 | 91.48 |
| 2026-08-18 | 91.75 |
| 2026-08-17 | 88.54 |
| 2026-08-14 | 90.54 |
| 2026-08-13 | 89.30 |
| 2026-08-12 | 90.85 |
| 2026-08-11 | 90.68 |
| 2026-08-10 | 89.61 |
| 2026-08-07 | 87.43 |
| 2026-08-06 | 91.37 |
| 2026-08-05 | 129.87 |
| 2026-08-04 | 124.75 |
| 2026-08-03 | 124.31 |
| 2026-07-31 | 128.72 |
| 2026-07-30 | 134.14 |
| 2026-07-29 | 133.52 |
| 2026-07-28 | 136.20 |
| 2026-07-27 | 133.42 |
| 2026-07-24 | 131.07 |
| 2026-07-23 | 130.98 |
| 2026-07-22 | 133.71 |
| 2026-07-21 | 135.43 |
| 2026-07-20 | 131.93 |
| 2026-07-17 | 136.53 |
| 2026-07-16 | 132.94 |
| 2026-07-15 | 133.13 |
| 2026-07-14 | 128.48 |
| 2026-07-13 | 129.97 |
| 2026-07-10 | 132.94 |
| 2026-07-09 | 137.92 |
| 2026-07-08 | 136.58 |
| 2026-07-07 | 132.60 |
| 2026-07-06 | 124.94 |
| 2026-07-02 | 123.69 |
| 2026-07-01 | 123.83 |
| 2026-06-30 | 125.66 |
| 2026-06-29 | 128.24 |
| 2026-06-26 | 129.39 |
| 2026-06-25 | 127.91 |
| 2026-06-24 | 131.17 |
| 2026-06-23 | 125.90 |
| 2026-06-22 | 127.76 |
| 2026-06-18 | 125.61 |
| 2026-06-17 | 125.66 |
| 2026-06-16 | 123.02 |
| 2026-06-15 | 122.59 |
| 2026-06-12 | 116.84 |
| 2026-06-11 | 117.84 |
| 2026-06-10 | 111.33 |
| 2026-06-09 | 109.22 |
| 2026-06-08 | 103.23 |
| 2026-06-05 | 101.74 |
| 2026-06-04 | 105.19 |
| 2026-06-03 | 102.32 |
| 2026-06-02 | 99.63 |
| 2026-06-01 | 102.89 |
| 2026-05-29 | 102.84 |
| 2026-05-28 | 102.75 |
| 2026-05-27 | 101.36 |
| 2026-05-26 | 101.17 |
| 2026-05-22 | 99.97 |
| 2026-05-21 | 100.69 |
| 2026-05-20 | 98.10 |
| 2026-05-19 | 93.45 |
| 2026-05-18 | 95.99 |
| 2026-05-15 | 102.17 |
| 2026-05-14 | 103.37 |
| 2026-05-13 | 103.95 |
| 2026-05-12 | 99.15 |
| 2026-05-11 | 101.79 |
| 2026-05-08 | 101.45 |
| 2026-05-07 | 99.01 |
